Page 1 of 1

Pfizer Discontinues Twice-Daily Obesity Pill After Study Showed High Side Effect Rates

Posted: Sat Dec 02, 2023 1:56 pm
by claireokc
ImagePfizer said it won't put the twice-daily version of its experimental weight-loss pill, called danuglipron, into further testing.

Source: https://www.theepochtimes.com/article/p ... es-5539624